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1. Introduction
Nutritional deficiencies have long been recognized as an important problem among HIV-1-
seropositive individuals. They have a great demand for nutrients because of the stress placed
on their immune systems. Moreover, poor nutrition may also affect drug effectiveness or
increased toxicity [34-37]. It has been shown that micronutrient deficiencies are associated with
more rapid HIV-disease progression and higher HIV-1 related mortality [38-40]. Supplemen‐
tation of micronutrient has delayed time to AIDS and improved survival, suggesting that
supplementation could offer a simple and relatively inexpensive strategy to slow HIV-1
progression [41, 42].
HIV infected patients present changes in components of the antioxidant defense system, which
may be the result of excessive production of oxygen-derived species during the development
of the disease (Pace and Leaf, 1995) and that cells infected with HIV can enhance production
of O2•− [43]. This phenomenon combined with a deficiency in key antioxidant enzymes
superoxide dismutase and catalase, and a decreased concentrations of the antioxidant vitamins
[44] may lead to severe oxidative stress in HIV-infected patients. Humans infected with human
immunodeficiency virus (HIV) have been shown to be under chronic oxidative stress [44-46],
which is the result of imbalance between free radical (or pro-oxidant) production and antiox‐
idant action. In HIV infection, oxidative stress may be caused by both overproduction of
reactive oxygen species (ROS) and a simultaneous deficiency of antioxidant defenses [47, 48].
Oxidative stress induced by ROS play a critical role in the stimulation of HIV replication and
the development of immunodeficiency [49, 50].
© 2014 The Author(s). Licensee InTech. This chapter is distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/3.0), which permits unrestricted use,
distribution, and reproduction in any medium, provided the original work is properly cited.
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Figure 2. Vitamin E level of HIV infected individuals and healthy subjects (μg /ml)
Many studies have focused on the role of nutritional supplements to attenuate signs and
symptoms of HIV. Of these, some have reported favorable results, while many others have
reported no benefit of the selected nutrient. Despite these mixed findings, recommendations
for the use of nutritional supplements for the purposes of attenuating HIV are rampant. Based
on this background, we have assessed the antioxidant status among HIV-infected patients on
oxidative stress after antioxidant supplementation.
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2. Subjects and methods
2.1. Subjects
Open clinical trial study was implemented to access antioxidant status among HIV-infected
male volunteers in Latvia. Twenty six HIV-positive males (age 35.3 ± 2.5) whose serostatus are
known were studied. They were recruited among two non-governmental HIV infected
patients’ support organizations by “snow-ball” methodology using gatekeepers as contact
persons. All participants in the research study were volunteers and their agreement to
participate was get through their gatekeepers. The HIV-infected subjects represented a broad
range of disease progression. None of the screened subjects had (CD4) T cell counts less than
200x109/L.
Exclusion criteria for the study groups were as follows: they were over 18 years old, have not
used antioxidants as food supplement two months before the study, had no active opportun‐
istic infections or malignancies, had readily mobile, and were no drug users. Any information
of partner identifications was not used in the written information
For the control group 10 uninfected males were selected among uninfected friends and
relatives of HIV-infected individuals. Control subjects had no acute or chronic illness and were
not taking any medications or nutritional supplements.
HIV-infected individuals used food supplements– antioxidant cocktail for 6 month, including
250 mg L-carnitine (Bio-CarnitineTM), 800 μg vitamin A, 15 mg vitamin E, 90 mg vitamin C, 2
mg vitamin B6, 15 mg Zn, 100 mg CoQ10 and 75 μg selenium (organic) (Bio-SeleniumTM+Zn) a
day. All subjects underwent an initial screening and after 6 months that included an anthro‐
pometric (weight and height) and biochemical (complete blood count, bilirubin, albumin, from
liver panel-alanine aminotranferase (ALT) and alkaline aminotranferase (), from lipid profile
total holesterol and triglicerides. All patients were evaluated with regard to the blood antiox‐
idant system, specifically superoxide dismutase (SOD), catalase (CAT) selenium-dependent
glutathione peroxidase (GSH-Px, trace element selenium, and α-tocopherol).
Participants will be involved in the study only after obtaining informed consent. The study
protocol was approved by the ethics committee of the Latvian Institute of Cardiology for
Clinical and Physiological Research, Drug and Pharmaceutics Product Clinical Investigation.
2.2. Laboratory analysis
After overnight fasting, venous blood samples were collected from all study subjects. Bio‐
chemical determinations were done at the hospital laboratory. CD4+and CD8+cell count was
estimated by FACSscan flowcytometry (BD Becton Dickimon). Alanine aminotranferase (ALT)
and alkaline aminotranferase were estimated by kinetic reaction (Hitachi 917, Roche Diagnos‐
tics), bilirubin, albumin and total protein by two point colour reaction (Hitachi 917, Roche
Diagnostics). From lipid profile total holesterol and triglycerides were estimated by using
fermentative colour reaction (Hitachi 917, Roche Diagnostics). Blood antioxidant system was
evaluated at Riga Stradinš University laboratory. Selenium and α-Tocophrol concentrations
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in plasma were measured using fluorometric method. Other measurements were also included
such as catalase and GSHPX.
2.3. Statistical analyses
Using the SPSS 14.0 for Windows software standard version, statistical analyses were per‐
formed. All group data are expressed as means ± SEMs. The HIV-positive group was compared
with the seronegative control subjects by using one way ANOVA. The minimal level of
significance was identified at P < 0.05. All patients were evaluated with regard to the blood
antioxidant system, specifically superoxide dismutase (SOD) and glutathione peroxidase.
3. Results
Subject characteristics, including CD4+cell count, CD8+cell count, and CD4/CD8 ratio, weight,
body mass index (BMI, in kg/m2), are shown in Table 1. At initial screening HIV-infected
subjects were significantly lower weight and BMI compared to healthy subjects. There were
insignificant changes between initial screening and after 6 months. The range of CD4+cell
counts was broad, from 282 to 1830 x 106 cells/L at the initial screening and from 323 to 1687
after 6 months CD4/CD6 ratio was from 0.1 to 1.7 at the initial screening and from 0.1 to 3.4
after 6 months of using food supplements, CD8+cell counts was from 272 to 4525 at the initial
screening and from 222 to 4851 after 6 months.
Baseline After 6 months
n Mean±SE n Mean±SE
Weight HIV-infected 26 73.1±2.1 13 74.7±2.8
healthy uninfected 10 82.4±2.6 9 83.3±2.7
p<0.05 p<0.05
BMI HIV-infected 26 22.5±0.6 13 23.0±0.8
Healthy 10 24.7±0.7 9 25.1±0.7
p<0.05 NS
CD4+ HIV-infected 25 698.4±74.3 21 743.6±87.4
CD8+ HIV-infected 25 1641.9±188.1 21 1341.0±216.1
CD4+/CD8 HIV-infected 25 0.6±0.1 21 0.9±0.2
Table 1. Effect of antioxidant supplementation on body weight, body mass index and immune function in HIV
patients.
Antioxidant status is shown in Table 2. At the baseline HIV-positive patients had significantly
lower GSHPX and CAT concentrations compare to healthy subjects (p<0.05), but did not differ
after 6 months using food supplements. There were insignificant differences in SOD and MDA
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measurements and α-Tocopherol concentration at the initial screening, but differed signifi‐
cantly after 6 months compare to HIV-infected and healthy individuals. Changes of biochem‐
ical measurements (alanine aminotranferase, alkaline aminotranferase, bilirubin, albumin and
total protein, total holesterol and triglicerides) were not significant between groups of HIV-
infected and healthy individuals as well as at the initial screening and after 6 months after use
of food supplements. Additionally, two HIV-infected individuals from 26 involved in the
study reported that after the use of antioxidant cocktail, gingival bleeding was stopped. One
reported this symptom for two years before the study and one reports half a year this problem
before study.
Measuremetns groups Baseline After 6 months
n Mean±SE n Mean±SE p
GSHPX infected 25 46.5±1.1 19 45.6±1.3 NS
healthy 10 50.9±1.6 9 49.5±0.7 NS
p 0.036 NS
CAT infected 26 1023.5±164.1 19 350.3±22.3 0.01
healthy 10 317.4±34.6 9 377.7±13.1 NS
0.013 NS
SOD infected 25 1074±68.3 19 1419.3±56.6 0.001
healthy 10 1293.7±36.6 9 1172.8±30.4 0.023
NS 0.008
TAS infected 24 1.0±0.0 17 1.5±0.0 0.001
healthy 10 1.4±0.0 9 1.4±0.0 NS
NS NS
VITE infected 26 10.8±0.8 19 13.2±1.2 NS
healthy 10 9.2±1.0 9 7.4±0.1 NS
NS 0.003
SE infected 25 47.4 21 64.0±3.7 0.000
healthy 10 51±3.0 9 53.9±3.1 NS
NS NS
MDA infected 24 3.5±0.1 17 5.1±0.3 0.000
healthy 10 3.4±0.2 9 3.4±0.2 NS
NS 0.000
Table 2. Effect of antioxidants supplementation on antioxidant enzymes, selenium, vitamin E and lipid peroxidation in
HIV patients.
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4. Discussion
There has been increasing interest in the application of antioxidants to many diseases as
information is constantly gathered linking the development of HIV to oxidative stress [51].
Antioxidants are believed to function interactively and synergistically to neutralize reactive
oxygen species (ROS). Reactive oxygen species include molecules like hydrogen peroxide; ions
like the hypochlorite ion; radicals like the hydroxyl radical; and the superoxide anion, which
are an ion and a radical.
All subjects from the current study are at low serum selenium level (which is about 80 – 120
μg /L in Europe), and stayed as that even after use of antioxidants supplements, including
selenium. Similar trend was also notice in the selenoenzyme glutathione peroxidase (GSHPx)
level among HIV patients. Low serum selenium was defined as a serum level ≤ 85 μg/l [52].
Selenium deficiency, more than any other nutrient, has been documented to correlate with
progression and mortality of HIV [53]. Selenium is needed for the proper functioning of the
immune system, and appears to be a key nutrient in counteracting the development of
virulence and inhibiting HIV progression to AIDS [54]. When taken as a supplement, selenium
modulates the cellular response to oxidative stress, inducing a faster restoration of the
endogenous antioxidative defence system against the production of reactive oxygen species
[55]. Glutathion peroxidase controls the interacellular level of hydrogen peroxide, reducing
the formation of reactive oxygen species that can induce lipid peroxidations with consequent
damage to the cellular membranes [56].
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Figure 3. Selenium level of HIV infected individuals and healthy subjects (μ/g Hb)
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The loss of CD4 T lymphocytes is a central factor in the progression of HIV infection to AIDS.
The key role of these cells in regulating and amplifying the immune response means that any
decline in their number results in deficits in both humoral and cell-mediated immunity [57].
Both the CD4 percentage and the CD4:CD8 ratio are also affected by changes in the number
of CD8 cells, which tends to rise through the course of HIV infection [58].This study demon‐
strates that after supplementation, there is an increase in CD4 T cells in HIV patients. Several
research studies have indicated that the apoptosis of CD4 cells contributing to HIV progression
does not result solely from HIV infection, but largely from antioxidant imbalances in the host
[43, 59, 60]. Activation of latent HIV state can be stimulated in the presence of reactive oxygen
species (ROS) through the stimulation of oxygen-responsive transcription factors, specifically
NF-kB, which induces HIV replication in the infected T-lymphocyte.
The mean serum malondialdehyde (MDA) concentrations in this study were significantly
elevated in HIV infected patients. Serum concentration of total serum antioxidant status (TAS)
was increased after supplementation. Our data indicate that severe oxidative stress occurs in
the serum of HIV patients in comparison with controls ones and the inclusion of antioxidants
in the therapeutic approach in managing HIV patients may prevent the additional free radicals
damage. It has been shown that cells infected with the HIV undergo a significant amplification
of O2− generation. This phenomenon combined with a deficiency in key antioxidant enzymes
(SOD and CAT) and a decreased concentration of the antioxidant vitamins, may lead to severe
oxidative stress in HIV-infected patients. Consequently these conditions may in turn be
responsible for the DNA base modifications observed in this study [43]. Serum MDA adducts
also tended to correlate inversely with expression of CD127 on T cells was shown [61]. Study
in placenta, umbilical cord blood and infant blood in HIV/ART-exposed infants compared with
uninfected controls [62] showed that placental mitochondria malondialdehyde (MDA)
concentrations and mtDNA content in placenta and cord blood were similar between groups.
Supplementation with antioxidant vitamins prevents oxidative modification of DNA in
lymphocytes of HIV-infected patients [44]. Furthermore, as an antioxidant, vitamin E [63]and
atherosclerotic lesions contain oxidized lipids [64], therefore, supplementation with vitamin
E would decrease heart disease risk. It has been reported that α-tocopherol concentrations in
serum are regulated by the α-tocopherol transfer protein and are dependent on serum lipid
concentrations because α-tocopherol is non-specifically transported by lipoproteins [63].
Serum micronutrient concentrations along with surrogate markers of atherosclerosis in a
cohort of HIV infected adults were studied [65](Falcone et al. 2010), the highest tertile of serum
vitamin E concentration was associated with higher common and internal carotid intima-
media thickness (c-IMT) and coronary artery calcium (CAC) scores [65]. The authors concluded
that elevated serum vitamin E values may increase the risk of cardiovascular complications in
HIV-infected adults [65].
There appears to be a possible role for antioxidants supplements. However, these supplements
cannot effectively eliminate HIV signs and symptoms and the optimal dosage of these nutrients
is (whether used alone or in combination) has to defined
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